Results 111 to 120 of about 2,227,737 (406)

Risk of adverse events with liraglutide in heart failure with reduced ejection fraction: A post hoc analysis of the FIGHT trial

Diabetes, obesity and metabolism, 2022
To perform a post hoc analysis of the FIGHT trial, evaluating the effect of liraglutide (vs. placebo) on the totality of events in patients with heart failure with reduced ejection fraction (HFrEF).
J. Neves, F. Vasques-Nóvoa, M. Borges-Canha, A. Leite, Abhinav Sharma, D. Carvalho, M. Packer, F. Zannad, A. Leite-Moreira, João Pedro Ferreira   +9 more
semanticscholar   +1 more source

Comparison of BNP and NT-proBNP in patients with heart failure and reduced ejection fraction [PDF]

, 2020
Both BNP (B-type natriuretic peptide) and NT-proBNP (N-terminal pro B-type natriuretic peptide) are widely used to aid diagnosis, assess the effect of therapy, and predict outcomes in heart failure and reduced ejection fraction.
Desai, Akshay S., Jhund, Pardeep S., Kristensen, Soren Lund, Køber, Lars, McMurray, John J.V., Packer, Milton, Prescott, Margaret F., Rorth, Rasmus, Rouleau, Jean L., Solomon, Scott D., Swedberg, Karl, Welsh, Paul, Yilmaz, Mehmet B., Zile, Michael R.   +13 more
core   +2 more sources

Ischemic Myocardium Targeting Peptide‐Guided Nanobubbles for Multimodal Imaging and Treatment of Coronary Microvascular Dysfunction

Advanced Healthcare Materials, EarlyView.
Nanobubbles functionalized with indocyanine green and ischemic myocardium‐targeting peptide effectively target cardiomyocytes and enable the multimodal (fluorescence, ultrasonic, and photoacoustic) imaging of ischemic myocardium in mice with coronary microvascular dysfunction (CMD).
Bo Yu, Ziwei Pang, Jing Zhao, Jingyi Xue, Hsuan Lo, Tiancheng Gu, Ping Zhang, Jiawei Tian, Guo‐Qing Du   +8 more
wiley   +1 more source

Combination therapy of midodrine and droxidopa for refractory hypotension in heart failure with preserved ejection fraction per a pharmacist’s proposal: a case report

Journal of Pharmaceutical Health Care and Sciences, 2021
Background Patients with chronic heart failure (CHF) are often treated using many diuretics for symptom relief; however, diuretic use may have to continue despite hypotension development in these patients.
Yuki Asai, Tomoaki Sato, Daisuke Kito, Takanori Yamamoto, Iwao Hioki, Yasuhisa Urata, Yasuharu Abe   +6 more
doaj   +1 more source

Fine-tuning pre-trained extractive QA models for clinical document parsing [PDF]

arXiv, 2023
Electronic health records (EHRs) contain a vast amount of high-dimensional multi-modal data that can accurately represent a patient's medical history. Unfortunately, most of this data is either unstructured or semi-structured, rendering it unsuitable for real-time and retrospective analyses.
arxiv  

Excess Mortality Associated with Functional Tricuspid Regurgitation Complicating Heart Failure with Reduced Ejection Fraction.

Circulation, 2019
BACKGROUND Functional tricuspid regurgitation (FTR) is common in reduced ejection-fraction heart-failure (HFrEF) and mostly consequent to pulmonary hypertension (PHTN).
G. Benfari, C. Antoine, W. Miller, P. Thapa, Y. Topilsky, A. Rossi, H. Michelena, S. Pislaru, M. Enriquez-Sarano   +8 more
semanticscholar   +1 more source

Weight change and clinical outcomes in heart failure with reduced ejection fraction: insights from EMPEROR‐Reduced

European Journal of Heart Failure, 2022
Baseline body mass index (BMI) and weight loss promoted by sodium–glucose cotransporter 2 inhibitors may impact outcomes in patients with heart failure with reduced ejection fraction (HFrEF).
S. Anker, M. S. Khan, J. Butler, A. Ofstad, B. Peil, E. Pfarr, W. Doehner, N. Sattar, A. Coats, G. Filippatos, J. Ferreira, F. Zannad, S. Pocock, M. Packer   +13 more
semanticscholar   +1 more source

Advancements in Understanding the Physicochemical Properties of Reticular Materials: An In Situ and Operando Spectroscopic Perspective

Advanced Materials, EarlyView.
This review explores how in situ and operando spectroscopic techniques reveal the real‐time behavior of reticular materials, including MOFs and COFs. These methods track material formation and functionalization, structural changes, defect formation, dynamic responses to external triggers, and catalytic processes.
Bettina Baumgartner, Anna Wach, Xinwei Ye, Evelyn Ploetz, Bert M. Weckhuysen   +4 more
wiley   +1 more source

Effect of aggressive diuresis in acute heart failure with reduced and preserved ejection fraction

ESC Heart Failure, 2021
Aims Heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF) had distinct haemodynamic characteristics in the setting of acute heart failure.
Xin He, Bin Dong, Ruicong Xue, Jingjing Zhao, Zexuan Wu, Yuzhong Wu, Yuanyuan Zhou, Dexi Wu, Yugang Dong, Jiangui He, Chen Liu   +10 more
doaj   +1 more source

Large and Small Animal Models of Heart Failure With Reduced Ejection Fraction

Circulation Research, 2022
Heart failure (HF) describes a heterogenous complex spectrum of pathological conditions that results in structural and functional remodeling leading to subsequent impairment of cardiac function, including either systolic dysfunction, diastolic ...
P. Pilz, J. Ward, W. Chang, A. Kiss, Edward Bateh, Alokkumar Jha, S. Fisch, B. Podesser, R. Liao   +8 more
semanticscholar   +1 more source